|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-2-12
|
|
pubmed:abstractText |
To assess the efficacy of latanoprost additive therapy in patients with intraocular pressure (IOP) out of control while taking maximum-tolerated medications and to determine whether pilocarpine therapy has a dose-dependent adverse effect on the efficacy of latanoprost therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
386-90
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9951495-Adult,
pubmed-meshheading:9951495-Aged,
pubmed-meshheading:9951495-Aged, 80 and over,
pubmed-meshheading:9951495-Dose-Response Relationship, Drug,
pubmed-meshheading:9951495-Drug Synergism,
pubmed-meshheading:9951495-Female,
pubmed-meshheading:9951495-Follow-Up Studies,
pubmed-meshheading:9951495-Glaucoma,
pubmed-meshheading:9951495-Humans,
pubmed-meshheading:9951495-Intraocular Pressure,
pubmed-meshheading:9951495-Male,
pubmed-meshheading:9951495-Middle Aged,
pubmed-meshheading:9951495-Ophthalmic Solutions,
pubmed-meshheading:9951495-Pilocarpine,
pubmed-meshheading:9951495-Proportional Hazards Models,
pubmed-meshheading:9951495-Prospective Studies,
pubmed-meshheading:9951495-Prostaglandins F, Synthetic,
pubmed-meshheading:9951495-Survival Analysis,
pubmed-meshheading:9951495-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
|
|
pubmed:affiliation |
Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
